UNSPSC 51385400: Nonsteroidal anti inflammatory quinolines

Nonsteroidal anti inflammatory drugs made of compounds consisting of a catabolite of tryptophan.

UNSPSC 51385400 Nonsteroidal anti inflammatory quinolines is a Class code that does not align with the state and local procurement activity currently tagged to it. Recent solicitations assigned to this code involve naloxone (an opioid antagonist, not an anti-inflammatory quinoline), direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products — none of which fall within the nominal scope of nonsteroidal anti-inflammatory quinolines. The mismatch suggests either a cataloging error in how opportunities are being tagged or a significant divergence between the code's intended pharmaceutical category and how state and local procurement offices are using the designation in practice.

Activity under this code appears limited and geographically dispersed. The most recent opportunities come from Seminole County, Florida (an IFB for naloxone and drug deactivation systems, response due July 26, 2023); the Texas Health and Human Services Commission (an RFI on direct-to-manufacturer prescription programs, response deadline April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance (an RFP for generic pharmaceuticals and OTC products, response due March 26, 2026). The involvement of a multistate cooperative purchasing vehicle alongside individual county and state agency activity suggests participation spans both single jurisdictions and cooperative agreements, though recent-opportunity volume is sparse. Given the fundamental mismatch between the code's pharmaceutical classification and what is actually being procured, vendors should verify tagging accuracy before investing significant business development effort under this code.